​

Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

OverviewForecastFinancialsChartTranscripts

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 5.18% insiders, and 94.81% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.61% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbeona Therapeutics-5.18%94.81%
SectorHealthcare Stocks 279.17%10.51%-189.68%
IndustryBiotech Stocks 63.95%10.67%25.38%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-2,350---1---
Sep 30, 20222-94.44%153,702-99.26%21.16%--100.00%2-60.00%
Jun 30, 202236-26.53%20,889,690-35.97%142.84%11-31.25%5-66.67%
Mar 31, 2022494.26%32,623,572-20.40%221.30%16-27.27%1525.00%
Dec 31, 202147-16.07%40,985,64961.98%416.24%2222.22%12-36.84%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.28M2.61%-
Vanguard US Total Market Shares ETF1.23M2.53%-
Vanguard Institutional Extnd Mkt Idx Tr678.10K1.39%-
Kennedy Micro Cap491.43K1.01%491.43K
Simplify Propel Opportunities ETF458.58K0.94%50.00K
Fidelity Extended Market Index228.42K0.47%3.18K
abrdn Life Sciences Investors224.36K0.46%-
BlackRock Extended Equity Market K96.05K0.22%-41.00
Extended Equity Market Fund K95.04K0.19%291.00
Arctic Aurora LifeScience I95.12K0.19%95.12K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 06, 2025Vazzano Joseph Walter Chief Financial OfficerSell$120.29K
Jun 06, 2025Seshadri Vishwas Chief Executive OfficerSell$342.57K
Jun 06, 2025O'Malley Brendan M. SVP, General CounselSell$70.78K
May 27, 2025Alvino Mark-Sell$12.76K
May 16, 2025Alvino Mark-Sell$45.44K

Insider Transactions Trends

DateBuySell
2025 Q2-5
2025 Q1-3
2024 Q4--
2024 Q3--
2024 Q262

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 5.18% insiders and 94.82% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 63.95%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Abeona Therapeutics shares, with 2.61% of its total shares outstanding invested in 1.28M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools